Successful use of guanfacine in a patient with chronic refractory cough: A case report

• Main Authors: Gregory W. Kirschen, Howard Kirschen, Edward Gabalski, Jonathan M. Waxner, Agnes Wohl
• Format: Article
• Language: English
• Published: Elsevier 2017-01-01
• Series: Respiratory Medicine Case Reports
• Subjects: Neurogenic cough; Sensory neuropathy; Somatic cough syndrome; Tic disorder; Alpha-2-adrenergic agonist
• Online Access: http://www.sciencedirect.com/science/article/pii/S2213007117301909

Chronic idiopathic cough is a common and often frustrating complaint for patients as well as providers. When common etiologies of cough are ruled out and/or do not respond to usual treatments, neurogenic cough should be considered as a diagnosis of exclusion. Here, we report on a 58-year-old woman with an 8-year history of chronic, treatment-refractory cough of unknown etiology that we diagnosed as neurogenic cough and successfully treated with guanfacine monotherapy, with rapid and durable improvement in symptoms. This case was particularly challenging for a number of reasons, including a distant past smoking history and previous pneumonia, a significant psychiatric history, and a mildly deviated nasal septum and nasal osteophyte, all or some of which could have contributed to the etiology of the cough. This case illustrates that neurogenic cough should be a diagnostic consideration in patients presenting with chronic cough in whom other treatment modalities have failed, and also suggests that the therapeutic use of guanfacine in this clinical setting warrants future investigation.